Akèy › Maladi fwa steatotik › Florid › Orlando
Etid klinik pou Maladi fwa steatotik nan Orlando, FL
9 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
- 89bio Clinical Study Site, Winter Park · 5 mi lwen
- 89bio Clinical Study Site, Ocoee · 10 mi lwen
- 89bio Clinical Study Site, Clermont · 24 mi lwen
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
- 89bio Clinical Study Site, Winter Park · 5 mi lwen
- 89bio Clinical Study Site, Maitland · 6 mi lwen
- 89bio Clinical Study Site, Ocoee · 10 mi lwen
- ak 1 plis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Ap rekriteFaz 2
- Charter Research LLC - Orlando, Orlando
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Ap rekriteFaz 3
- Charter Research - Orlando, Orlando
- Headlands Research Orlando, Orlando
- K2 Medical Research WINTER GARDEN, Clermont · 24 mi lwen
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Ap rekriteFaz 3
- Akero Clinical Study Site, Orlando
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Ap rekriteFaz 3
- GSK Investigational Site, Maitland · 6 mi lwen
- GSK Investigational Site, Kissimmee · 16 mi lwen
- GSK Investigational Site, Clermont · 24 mi lwen
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
Ap rekriteVolontè an sante akeyi
- AdventHealth Translational Research Institute, Orlando
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Ap rekriteFaz 3
- GSK Investigational Site, Maitland · 6 mi lwen
- GSK Investigational Site, Kissimmee · 16 mi lwen
- GSK Investigational Site, Clermont · 24 mi lwen
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- AdventHealth Translational Research Institute, Orlando
Etid Maladi fwa steatotik nan lòt vil
- San Antonio, TX17 etid
- New York City, NY16 etid
- Miami, FL16 etid
- San Diego, CA14 etid
- Austin, TX13 etid
- Houston, TX13 etid
- Richmond, VA12 etid
- Tucson, AZ10 etid
- Chandler, AZ10 etid
- St. Louis, MO9 etid
- Hialeah, FL9 etid
- Dallas, TX9 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Obèsite32 etid
- Kansè Metastatik29 etid
- Sipwa27 etid
- Maladi Alzheimer25 etid
- Dyabèt Tip 225 etid
- Kansè (tout kalite)24 etid
- Kansè nan tete23 etid
- Kansè ovè22 etid
- Kolit Ulseratif22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.